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Neural stem cells (NSCs) in the adult hippocampus
divide infrequently, and the molecules that modulate
their quiescence are largely unknown. Here, we show
that bone morphogenetic protein (BMP) signaling
is active in hippocampal NSCs, downstream of
BMPR-IA. BMPs reversibly diminish proliferation of
cultured NSCs while maintaining their undifferenti-
ated state. In vivo, acute blockade of BMP signaling
in the hippocampus by intracerebral infusion of
Noggin first recruits quiescent NSCs into the cycle
and increases neurogenesis; subsequently, it leads
to decreased stem cell division and depletion of
precursors and newborn neurons. Consistently,
selective ablation of Bmpr1a in hippocampal NSCs,
or inactivation of BMP canonical signaling in condi-
tional Smad4 knockout mice, transiently enhances
proliferation but later leads to a reduced number of
precursors, thereby limiting neuronal birth. BMPs
are therefore required to balance NSC quiescence/
proliferation and to prevent loss of the stem cell
activity that supports continuous neurogenesis in
the mature hippocampus.
INTRODUCTION
Quiescence of somatic stem cells is critically important for the
maintenance of tissue-specific germinal reservoirs during adult-
hood. Stem cells from diverse adult compartments are depleted78 Cell Stem Cell 7, 78–89, July 2, 2010 ª2010 Elsevier Inc.when forced to proliferate (Cheng et al., 2000; Kippin et al., 2005;
Ruzankina et al., 2007), and quiescence may function as
a protective mechanism that counteracts stem cell exhaustion.
In the mature mammalian nervous system, adult neural stem
cells (NSCs) generate new neurons throughout life, but there is
little information regarding the molecules that regulate their
relative quiescence. Adult NSCs are located in two specialized
brain niches: the subependymal zone (SEZ), which lines the
lateral ventricles, and the hippocampal subgranular zone (SGZ)
apposed to the innermost layer of the dentate gyrus (reviewed
by Temple and Alvarez-Buylla, 1999; Zhao et al., 2008). In the
latter, undifferentiated cells expressing the Sry-related high
mobility group (HMG) box transcription factor Sox2 are the
primary source for NSCs. On the basis of morphological criteria,
on the expression of unique sets of cellular markers, and on
lineage tracing, two types of lineage-related SOX2+ stem/pre-
cursor cells that contribute neuronal progeny have been identi-
fied in the SGZ: (1) radial SOX2+ cells, which bear a radial process
spanning the granule cell layer and express NESTIN, the gluta-
mate transporter GLAST, and the glial fibrillary acidic protein
GFAP among other markers (also named rA cells or type 1 cells),
and (2) nonradial SOX2+ cells (or type 2a), which may arise from
the radial cells and do not express GFAP. This distinction corre-
lates with a different proliferation state of the cells, as SOX2+
radial cells rarely divide whereas SOX2+ nonradial cells appear
to cycle relatively more often; consequently, it has been sug-
gested that the radial cell population constitutes a stem cell
reservoir (Seri et al., 2001, 2004; Filippov et al., 2003; Fukuda
et al., 2003; Kronenberg et al., 2003; Suh et al., 2007).
Although the phenotypes of both radial and nonradial SOX2+
cell types have been extensively characterized in numerous
studies, our molecular understanding of their regulation is still
very limited. In vivo cycling of the adult hippocampal SOX2+
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Figure 1. Adult Hippocampal Radial Stem Cells Express BMPR-IA
(A) Confocal microscopy images of adult hippocampal mouse sections
showing GFAP (blue), NESTIN (green), and BMPR-IA (red) triple-labeled
processes (arrow) of NSCs projecting radially from the SGZ (dotted line).
See also Figure S1 for additional data. The scale bar represents 20 mm.
(B) Section from an adult tg-Sox2-GFP mouse. Arrow points to a radial stem
cell process (immunoreactive for GFP, green) labeled for BMPR-IA (red). The
scale bar represents 20 mm.
(C) BMPR-IB staining was detected in NeuN+ granule neurons located in
the granule cell layer and in some SOX2+ cells (arrows) located in the SGZ.
The scale bar represents 10 mm.
(D) Immature neurons expressing PSA-NCAM also stained for BMPR-IB. The
scale bar represents 20 mm. H, hilus. See scheme in Figure S7.
Cell Stem Cell
BMPs Regulate Adult Neural Stem CellsNSC population is relatively low, and most cells are held in
a quiescent state. Indeed, in young transgenic mice harboring
the green fluorescent protein (GFP) under the control of the
murine Sox2 promoter, less than 10% of the Sox2-GFP+ cells
in the SGZ colabel with cell proliferation markers (Suh et al.,
2007). As rodents grow old (Hattiangady and Shetty, 2008;
Aizawa et al., 2009), SOX2+ cells lose proliferative capacity, sug-
gesting that adult NSCs may have a finite number of cycles. This
finding points to a role for quiescence in the maintenance of
the regenerative potential of the hippocampal dentate gyrus.
However, how quiescence of SOX2+ stem cells is governed
during adulthood is still an unresolved question.
Among the signaling pathways that govern stem cells across
phylogeny, bone morphogenetic proteins (BMPs) have emerged
as critical regulators of stem cell self-renewing divisions and
maintenance in a wide variety of niches (reviewed by Varga
and Wrana, 2005; Morrison and Spradling, 2008). BMPs belong
to the TGF-b superfamily of cytokines and are pleiotropic mole-
cules that exert a plethora of effects in the nervous system,
ranging from dorsoventral patterning of the embryonic neural
tube to proliferation, apoptosis, neurogenesis, and gliogenesis
(reviewed by Panchision and McKay, 2002; Hall and Miller,
2004; Chen and Panchision, 2007). In the adult brain environ-
ment, the contribution of BMP signaling to stem cell regulation
remains largely unexplored, although recently it has been sug-
gested that the BMP pathway may have a central role in modu-
lating NSC function (Lim et al., 2000; Coskun et al., 2001; Colak
et al., 2008; Bonaguidi et al., 2008).
Here, we test the requirement of endogenous BMP signaling
for the regulation of hippocampal NSCs. Both genetic deletion
of Bmpr1a and Smad4 in adult NSCs and infusion of the BMP
antagonist Noggin show that canonical signaling downstream
of the BMP type IA receptor is a key mediator of quiescence in
adult NSCs. We evaluate BMP function both in vitro and in vivo
and conclude that BMPR-IA is essential in regulating the equilib-
rium between stem cell proliferation and quiescence in the SGZ,
preventing the premature depletion of NSC activity in the mature
hippocampus.
RESULTS
BMPR-IA Is Expressed by Adult Hippocampal
Radial NSCs
BMP ligands signal through a tetrameric complex formed by the
BMP type II receptor (BMPR-II) and different classes of BMP
type I receptors, the prototypic ones being BMPR-IA (ALK3)
and BMPR-IB (ALK6). Expression ofBmpr-II had been previously
documented in the hippocampus by in situ hybridization (So¨der-
stro¨m et al., 1996; Charytoniuk et al., 2000), so we analyzed type
I receptor expression by immunostaining. We found that radial
stem cells coexpressing GFAP and NESTIN were frequently
stained for BMPR-IA (Figure 1A). Consistently, BMPR-IA signal
was detected in GFP+ radial cells from transgenic mice express-
ing the GFP reporter under the regulation of the Sox2 promoter
(Figure 1B). In addition, the vast majority of GFAP+ astrocytes
in the dentate gyrus and the hilar region were immunoreactive
for BMPR-IA (Figure 1A and Figure S1, available online). In
marked contrast, BMPR-IB expression was mostly confined to
the neuronal population, given that NeuN+ mature neurons andPSA-NCAM+ immature neurons stained for BMPR-IB (Figures
1C and 1D). Some nonradial cells that formed clusters in the
SGZ expressed low levels of SOX2 and were also immunoreac-
tive for BMPR-IB (Figure 1C). Altogether, these findings sug-
gested that BMPR-IA might regulate an early event in adult
neurogenesis, whereas BMPR-IB might have a later role, during
neuronal differentiation.
Canonical BMP Signaling in the Adult Hippocampus
Is Active in Nondividing SGZ Cells
The interaction of BMPs with their receptors can trigger several
pathways, including the ‘‘canonical’’ Smad-mediated pathway,
in which activated BMPR-I phosphorylates the DNA binding
proteins SMAD1/5/8, causing their nuclear translocation. Immu-
nostaining with anti-phospho-SMAD1 (Ser463/465) was assessed
in adult animals that were briefly pulsed with the S-phase marker
5-bromodeoxyuridine (BrdU). P-SMAD1 staining revealed that
canonical BMP signaling is active in the majority of radial andCell Stem Cell 7, 78–89, July 2, 2010 ª2010 Elsevier Inc. 79
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Figure 2. BMP Signaling Is Active in Adult
Hippocampal Stem/Precursor Cells that
Are Not Cycling
(A) Confocal microscopy images of adult hippo-
campal mouse sections showing that most SOX2+
cells (blue) in the SGZ are immunoreactive for
P-SMAD1 (red) in their nucleus (green; fraction of
SOX2+ cells that were P-SMAD1+: 64% ± 1%,
average ± SEM, n = 2). Of these, 70% displayed
medium to high signal level. Confocal 3D recon-
struction of the boxed area, showing colocalization
of phosphorylated SMAD1 and SOX2 proteins in
some SGZ nuclei (left arrow), is shown on the right.
Top shows the x-z plane; left shows the y-z plane.
The scale bar represents 40 mm.
(B) Image of a section from a tg-Sox2-GFP trans-
genic mouse showing the P-SMAD1+ nucleus of
radial (B0) and nonradial (B00) Sox2-expressing
NSCs (immunoreactive for GFP, green). The scale
bar represents 40 mm.
(C) Section from an adult animal pulsed with BrdU
(four injections every 2 hr) and euthanized 1 hr later.
The immunostaining and the confocal analysis
shows SOX2+ cells that incorporated BrdU and
were negative for P-SMAD1 (dotted circles).
(D) Most DCX+ immature neurons (green) in the SGZ
stained for P-SMAD1. Note that nuclei of densely
packed mature neurons located in the granule layer
were also immunoreactive for P-SMAD1. The scale
bar represents 40 mm.
(E) Detail from a section of an adult animal
labeled with BrdU, showing a newborn neuron
(DCX+BrdU+) that stained for P-SMAD1 apparently
migrating into the granule layer. As shown in (E0),
we could observe some newborn neurons with
poor dendritic processes that did not stain for
P-SMAD1 (arrow). See also Figure S2 for addi-
tional data. See scheme in Figure S7.
Cell Stem Cell
BMPs Regulate Adult Neural Stem Cellsnonradial SOX2+ cells (Figures 2A and 2B), but the pathway is pref-
erentially inactive in the few cells that have entered a new round of
cell division (most SOX2+ cells that incorporated BrdU were nega-
tive for P-SMAD1: 92% ± 8%, average ± SEM, Figure 2C). In addi-
tion, the majority of the doublecortin-positive (DCX+) and
NEUROD1+ immature neurons/neuroblasts stained for P-SMAD1
(Figure 2D and Figure S2). When adult animals were pulsed with
BrdU for 3 days for labeling and tracking newborn cells, we
observed that most of the DCX+BrdU+ newly generated neurons
that were extending dendritic processes toward the molecular
layer were P-SMAD1+ (Figure 2E); however, we also found some
more immature DCX+BrdU+ cells positioned along the SGZ, with
shorter dendrites, that were negative for P-SMAD1 (Figure 2E0),
suggesting that canonical signaling becomes reactivated in the
neuronal progeny shortly after its commitment. Together, our
results indicated thatBMP signaling is inactive inmostproliferating
SGZ cells, whereas it is active in nondividing cells, including the
quiescent SOX2+ NSC population and the differentiated neurons.
BMP2/4 Trigger Canonical Signaling in Adult
Hippocampal NSC Cultures Expressing BMPR-IA
We next examined the role of BMP signaling in adult hippo-
campus-derived NSCs (AH-NSCs) that can mimic the initial80 Cell Stem Cell 7, 78–89, July 2, 2010 ª2010 Elsevier Inc.events of neurogenesis under proliferating conditions. Immunos-
taining and RT-PCR analysis revealed that AH-NSCs expressed
Bmpr1a and Bmpr2, whereas Bmpr1b expression was only de-
tected at very weak levels (Figures 3A and 3B). Of note, Bmpr1a
expression was decreased, whereas Bmpr1b expression was
progressively increased upon neuronal differentiation of AH-
NSCs (Figure S3). Given that BMPR-IA preferentially binds
ligands from the Dpp class (BMP2/4) as opposed to the 60A class
(BMP5-8) (ten Dijke et al., 1994), we challenged AH-NSCs with
the purified recombinant BMP2 and BMP4 proteins. BMP2/4
triggered phosphorylation and nuclear translocation of SMAD1
(Figures 3C and 3D) and upregulated the expression of several
SMAD targets, such as Id1-4, Hes1, or the inhibitory Smad6/7
genes (Figures 3E and 3F), showing that AH-NSCs responded
to BMPs through activation of the canonical pathway.
BMP2/4 Treatment Decreases Proliferation
and Increases Quiescence of AH-NSC Cultures
We assayed for proliferation effects of BMPs in AH-NSCs grown
under self-renewing conditions in the presence of fibroblast
growth factor 2 (FGF2). Under mitogenic stimulation, exposure
to increasing BMP2 doses markedly decreased the percentage
of cells that incorporated BrdU (p < 0.05, Figures 4A and 4B).
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Figure 3. BMP Treatment Activates Canon-
ical Signaling in AH-NSC Cultures Express-
ing BMPR-IA
(A) Immunofluorescent microscopy image showing
BMPR-IA signal in AH-NSCs, growing in the pres-
ence of FGF2. The scale bar represents 10 mm.
(B) Bmpr-1a and Bmpr-II are expressed in prolifer-
ating AH-NSC cultures, as detected by RT-PCR.
Bmpr-1b expression is low (average threshold
cycle calculated by real-time quantitative RT-PCR
[Cp ± SEM]: 28.4 ± 0.3 for Bmpr-1a and 31.0 ± 0.1
for Bmpr-1b). See also Figure S3 for additional
data.
(C) Immunofluorescent analysis of BMP2-treated
and untreated AH-NSCs, showing activation of
canonical BMP signaling through increased phos-
phorylation and nuclear translocation of SMAD1.
The scale bar represents 10 mm.
(D) Western blot analysis of protein extracts from
BMP2-treated and untreated AH-NSCs corrobo-
rating the activation of canonical signaling through
phosphorylation of SMAD1.
(E) mRNA expression of several SMAD target
genes by RT-PCR.
(F) Relative luciferase activity in AH-NSCs electro-
porated with Id1-reporter construct upon BMP2/
BMP4 stimulation.
Cell Stem Cell
BMPs Regulate Adult Neural Stem CellsConsistently, cell cycle analysis by flow cytometry indicated that
BMP treatment increased the proportion of cells in G0/G1 while
decreasing the proportion of AH-NSCs in S phase and G2/M
phases (Figure S4). The decrease in proliferation was not due
to cell death (propidium iodide labeled cells by flow cytometry:
1.26% ± 0.43% in FGF2 versus 0.95% ± 0.06% in FGF2+BMP4,
p = 0.28) or to differentiation, given that the expression of the
NSC marker SOX2 was maintained in the culture (Figure 4A).
Rather, BMP appeared to antagonize the proliferative function
of FGF2 because increasing the amount of mitogen in the
medium partially blocked the dose-dependent effect of the
BMP treatment on proliferation (Figure S5; Pera et al., 2003).
We next explored whether BMP treatment increased the
quiescent (G0-arrested) cell fraction. Given that G0 cells are in
a lower metabolic state and do not require robust RNA transcrip-
tion, they can be identified by a 2N DNA content and a low level
of RNA, with Hoechst 33342 and the Pyronin Y RNA dye. Two-
parameter flow cytometry showed that the fraction of G0 cells
increased an average fold of 1.8 ± 0.2 after BMP exposure
(n = 3, Figure S4). Moreover, when the BMP-treated FACS-
sorted G0 cells were challenged with the BMP antagonist
Noggin, 81.3% ± 10.7% of the cells were NESTIN+ (not shown)
and 21.6% ± 7.8% of the cells started dividing after 24–48 hr
(Figure S4). This finding indicated that the majority of the BMP-
treated G0 cells maintained stem/precursor properties and could
re-enter the cell cycle. Thus, Noggin reverted the G0 arrest
induced by BMP signaling on AH-NSCs.
To test whether culture conditions such as cell density and
adhesion influenced BMP functions, we also assayed for theeffects of BMPs on AH-NSCs seeded at a very low density
(0.5 cells/mL) and maintained as clonal floating aggregates
termed neurospheres. Comparable numbers of spheres were
formed in control medium with FGF2 or in medium containing
FGF2 and 50 ng/mL BMP2/4 (331.67 ± 49.14 spheres in FGF2
versus 323.50 ± 83.19 spheres in FGF2+BMP4, p = 0.46,
Figure 4C). We evaluated the proportion of cells per sphere
that were in the cell cycle, using an antibody directed against
Ki67, a protein that is present during all active phases of the
cell cycle but is absent from resting (G0) cells. The percentage
of Ki67+ cells was markedly diminished in the presence of
BMP4 (p < 0.05, Figures 4E and 4F), and accordingly, the
average diameter of the spheres was significantly decreased
(p < 0.05, Figures 4C and 4D). Consistent with our previous
results, cell death was unaffected (percentage of Caspase3+
cells per sphere: 0.64% ± 0.46% in FGF2 versus 1.22 ± 0.3%
in FGF2+BMP4, p = 0.29), and the proportion of cells that
were NESTIN+ or SOX2+ did not change (Figure 4E, percentage
of NESTIN+ cells per neurosphere: 83.65% ± 3.74% in FGF2
versus 97.72% ± 1.85% in FGF2+BMP4; percentage of SOX2+
cells: 89.27% ± 0.64% in FGF2 versus 92.6 ± 0.57% in
FGF2+BMP4). In addition, >80% of the Ki67 cells were immu-
noreactive for NESTIN and SOX2, indicating that, at early time
points, most G0 (Ki67
) cells were undifferentiated/immature
and not terminally differentiated cells (Figure S5). Nevertheless,
20% of the Ki67 cells expressed differentiation markers of
the oligodendroglial or astroglial lineage, but no significant
differences were found between control and BMP-treated
neurospheres.Cell Stem Cell 7, 78–89, July 2, 2010 ª2010 Elsevier Inc. 81
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Figure 4. BMP Treatment Decreases Prolif-
eration and Increases Quiescence of AH-
NSC Cultures
(A) Immunofluorescent analysis of BMP-treated or
untreated proliferating cells fixed at 2 days in vitro.
BMP2 decreases the proportion of cells that are
in S-phase (BrdU+, red) while maintaining the
expression of the NSC marker SOX2 (green). Scale
bars represent 20 mm.
(B) Quantitative analysis showing that increasing
concentrations of BMP2 decrease the percentage
of BrdU+ cells in AH-NSC cultures grown in prolif-
erating medium with FGF2 (n = 3).
(C) Bright-field images of adult hippocampal neu-
rospheres grown for 6 days in vitro. Note that
approximately equal numbers of neurospheres
are generated in the presence or absence of
BMP2; however, the decrease in sphere size in
BMP2-treated cultures is apparent. The scale bar
represents 100 mm.
(D) A plot of the diameter of spheres that were
generated after plating AH-NSCs in nonadherent
conditions at very low density (250 viable cells
per cm2, n = 3).
(E) Immunofluorescent analysis of BMP-treated or
untreated neurospheres fixed at 3 days in vitro.
BMP4 decreases the proportion of cells that are
in the cell cycle (Ki67+, green) while maintaining
the expression of the NSC marker NESTIN (red).
The scale bar represents 10 mm.
(F) BMP4 treatment decreases the percentage of
Ki67+ cells per neurosphere (n = 3).
(G) qRT-PCR analysis showing decreased Cyclin-
D1 and increased p21cip1/waf1 expression 4 days
after BMP2 treatment of adult hippocampal
sphere cultures (n = 2).
(H) The addition of Noggin (250 ng/mL) at day 6
progressively rescues the proliferating activity
(size) of the BMP-treated spheres, as measured
at days 8 and 15.
(I) Diagram depicting the experimental design
employed to purify DFFDA-retaining cells from
BMP4-treated neurospheres.
(J) Cytometry plot showing that BMP4 treatment
increased the percentage of DFFDAhigh cells from
11% to 27%.
(K) Bright-field image of purified BMP4-treated
DFFDAhigh cells plated in FGF2 + Noggin
(100 ng/mL), showing secondary sphere formation
after 48 hr. Paired Student’s t test relative to
control condition: *p < 0.05, **p < 0.01. The scale
bar represents 20 mm. See also Figures S4 and
S5 for additional data.
Cell Stem Cell
BMPs Regulate Adult Neural Stem CellsThe decreased proliferation and increased G0 cell fraction
after BMP exposure correlated with the upregulation of the cell
cycle inhibitor Cdkn1a (p21Cip1/Waf1) and the downregulation of
CyclinD1 (Figure 4G). In addition, Noggin treatment in the pres-
ence of FGF2 presumably antagonized endogenous BMP
effects by increasing the average sphere number (126% ± 4%)
and diameter (187% ± 27%) and the percentage of Ki67+ cells82 Cell Stem Cell 7, 78–89, July 2, 2010 ª2010 Elsevier Inc.(120% ± 9%). Moreover, in agreement with a previous report
(Bonaguidi et al., 2008), Noggin enhanced the net expansion of
hippocampal sphere cultures that were serially passaged over
1 month in the presence of FGF2 but was not sufficient to
promote proliferation of AH-NSCs (Figure S5).
At the level of clone size, the antiproliferative effect of BMP
signaling could be reversed when BMP was replaced with
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Figure 5. In Vivo Infusion of Noggin
Increases Proliferation of SOX2+ Radial
NSCs
(A) Diagram depicting the experimental design
employed. BrdU (seven injections every 2 hours)
was administered prior to euthanasia.
(B) P-SMAD1 immunostaining in hippocampal
sections from saline- and Noggin-infused mice.
Note that nuclear localization of P-SMAD1 is abol-
ished after Noggin exposure, demonstrating that
the treatment was effective. Scale bars represent
20 mm.
(C) Quantitative analysis showing that 1 week of
Noggin infusion enhanced cell proliferation in the
hippocampus. Proliferation was calculated by the
number of cells that incorporated BrdU per volume
of granule cell layer.
(D) Confocal microscopy images of adult hippo-
campal mouse sections showing the increase in
proliferative NSCs double labeled for SOX2 (blue)
and BrdU (red). Nuclei were stained with Sytox-
Green. Scale bars represent 40 mm.
(E) Immediately after 1 week of Noggin delivery,
the number of SOX2+ cells in S-phase increased.
(F) The percentage of radial cells (immunoreactive
for SOX2 and GFAP) that incorporated BrdU
increased; the proportion of nonradial cells (immu-
noreactive for SOX2 but not for GFAP) that incor-
porated BrdU did not change.
(G) The total number of SOX2+ cells per volume of
granule cell layer remained constant.
(H) The relative amount of radial and nonradial cells
was maintained.
(I) Noggin increased the percentage of radial
SOX2+ cells that are in the cell cycle (Ki67+).
(J) Confocal image showing that Noggin increased
cell cycle entry of the radial NSC population. The
scale bar represents 40 mm.
(K and L) The rate of proliferation of doublecortin-
expressing (DCX+) neuroblasts did not change
(K), although as shown in (L), the total number of
DCX+ immature neurons augmented. Unpaired
Student’s t test: *p < 0.05, **p < 0.01, and ***p <
0.001.
Cell Stem Cell
BMPs Regulate Adult Neural Stem CellsNoggin (see the recovery of sphere diameters, Figure 4H). We
confirmed this reversibility at the cellular level, by using the
cytoplasmic retention dye carboxy-DFFDA, which is subject to
dilution upon cell division. As illustrated in Figure 4I, we loaded
spheres that were growing for 2 days with DFFDA, and we
allowed them to grow for 4 additional days in FGF2+BMP4.
Addition of BMP4 clearly increased (2.5-fold) the DFFDAhigh
cell fraction (nondividing cells) relative to the control condition
(Figure 4J). When BMP-treated DFFDAhigh cells were FACS
sorted and were placed at low density in FGF2 + Noggin
medium, 46% ± 20% of the cells re-entered the cell cycle
(were Ki67+) and 35% ± 16% formed secondary clones
(Figure 4K). These results collectively indicated that BMPs coun-
teract the mitogenic stimulation of AH-NSCs by promoting the
entry of the cells into quiescence. The contribution of other
BMP signaling effects (i.e., cell cycle lengthening effects) to the
decrease in proliferation cannot be excluded and remain to be
explored.BMP Signaling Regulates the Balance between AH-NSC
Proliferation and Quiescence In Vivo
To assess the possibility that endogenous BMPs can regulate
proliferation of NSCs in the hippocampal niche, we delivered
Noggin into the lateral ventricle of the adult mouse brain. Animals
were infused over 1 week and, on the last day of infusion,
dividing cells were labeled with BrdU (Figure 5A). Acute delivery
of Noggin efficiently blocked BMP canonical signaling in the
hippocampus (Figure 5B) and increased the number of BrdU+
cells in the SGZ (3073 ± 283 in saline [n = 8] versus 5868 ±
1853 in Noggin [n = 4], p < 0.05, Figure 5C).
Noggin infusion enhanced by 2-fold the percentage of SOX2+
cells that were in S phase (p < 0.05, Figure 5D and 5E) but did not
influence the total number of SOX2+ cells in the SGZ (p = 0.335,
Figure 5G) or the relative proportion of radial and nonradial cells
(Figure 5H), suggesting that SOX2+ cells divided asymmetrically.
Interestingly, Noggin preferentially increased the proliferation
of the GFAP+SOX2+ radial stem cell population (p < 0.01,Cell Stem Cell 7, 78–89, July 2, 2010 ª2010 Elsevier Inc. 83
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Figure 6. Noggin Infusion Leads in the Long
Run to a Decrease in the Proliferative
Activity of SOX2+ Cells and of Label-Retain-
ing NSCs
(A) Diagram depicting the experimental design for
Noggin infusion and for the administration of CldU
and IdU.
(B) Quantitative analysis showing that the number
of SOX2+ cells that retain the proliferative label
CldU per volume of granule cell layer is decreased
3 weeks after pump removal.
(C) The number of NeuN+ mature granule neurons
marked with CldU is increased.
(D) The percentage of CldU+ cells that stained
for immature (DCX) and mature (NeuN) neuronal
markers is increased at the expense of SOX2+
cells. (n.d., not determined).
(E) The total number of SOX2+ cells and the
number of SOX2+ nonradial cells per volume of
granule cell layer decayed.
(F) Noggin exposure resulted 3 weeks later in
decreased hippocampal proliferation (decreased
number of IdU+ cells/mm3).
(G) Noggin exposure resulted in a reduction in the
proportion of SOX2+ cells undergoing cell division.
(H) The number of CldU+LRCs that were still
proliferating (incorporated IdU) was diminished.
Unpaired Student’s t test: *p < 0.05, **p < 0.01.
See also Figure S6 for additional data.
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BMPs Regulate Adult Neural Stem CellsFigure 5F), whereas the proportion of proliferating nonradial cells
(Figure 5F) or DCX+ neuroblasts remained constant (percentage
of DCX+ cells that were BrdU+: 5.4% ± 0.7% in saline versus
6.9 ± 2.6% in Noggin, p = 0.3, Figure 5K). Immunofluorescence
analysis with Ki67 further showed that the percentage of cycling
radial NSCs increased (Figures 5I and 5J), indicating that the
Noggin-mediated attenuation of BMP signaling recruited quies-
cent (G0) radial cells into the cycle. In accordance with the
increase in NSC division, hippocampal neurogenesis was aug-
mented upon Noggin administration, as scored by the number
of DCX+ immature neurons (p < 0.001, Figure 5L).
Blockade of BMP Signaling Leads to a Decrease
in Proliferation and to the Loss of SOX2+ Nonradial Cells
In another set of animals, Noggin infusion was combined with the
administration of two halogenated thymidine analogs to label and
distinguish proliferating cells at different time points (Figure 6A).
Noggin was administered over 1 week, and 5-clorodeoxyuridine
(CldU) was injected on the last day of infusion (day 7). Next, the
catheter connecting the pump to the cannula was sealed, and
animals were returned to the cages for 3 additional weeks. Prior
to euthanasia, animals received 5-iododeoxyuridine (IdU), which
allowed us to discriminate between CldU+ label-retaining stem
cells (LRCs) that remained in the SGZ after the proliferative burst
triggered by Noggin and IdU+ cells that were dividing 28 days
after they were first exposed to the BMP antagonist.
At least two major classes of cells in the hippocampal dentate
gyrus were expected to retain the CldU label: slowly dividing
SOX2+ NSCs that do not dilute CldU through division (LRCs)
and newborn neurons that incorporate CldU prior to cell cycle
exit. As shown in Figure 6B, the number of SOX2+CldU+ LRCs
per mm3 in the SGZ was significantly reduced in brains that84 Cell Stem Cell 7, 78–89, July 2, 2010 ª2010 Elsevier Inc.had been exposed to Noggin (619 ± 209 in saline [n = 5] versus
342 ± 124 in Noggin [n = 3], p < 0.05). Conversely, Noggin infu-
sion significantly increased the number of CldU+ cells that had
matured to granule neurons (p < 0.05, Figure 6C). Among the
cells that retained CldU, the proportion of SOX2+ undifferenti-
ated cells and that of their differentiated progeny (immature
DCX+ neurons or more mature NeuN+ neurons) were shifted
after Noggin infusion in favor of the differentiated phenotypes
(Figure 6D).
In Noggin-treated animals, we observed that total SOX2+ cell
numbers were diminished because of a reduction in SOX2+ non-
radial cells (p < 0.01, Figure 6E). Accordingly, and as measured
by anti-IdU immunostaining, overall proliferation in the SGZ
was also diminished (p < 0.05, Figure 6F). The percentage of
the SOX2+ cell population that was in S-phase declined (p <
0.05, Figure 6G), the birth of new IdU+DCX+ neurons showed
a marked tendency toward reduction (double-positive cells per
mm3: 4446 ± 729 in saline versus 2596 ± 702 in Noggin, p =
0.09), and the total number of DCX+ cells per mm3 was signifi-
cantly diminished (21417 ± 2844 in saline versus 14785 ± 4134
in Noggin, p < 0.05). Of note, the number of double-labeled
CldU+IdU+ cells in the SGZ decreased in the Noggin group
compared to the saline condition (p < 0.05, Figure 6H), pointing
to a restriction in the proliferative activity of LRCs.
To test the possibility that the loss of nonradial SOX2+ cells
was due to cell death, we examined the hippocampus at inter-
mediate time points after Noggin infusion (Figure S6). Despite
the progressive decline in the number of SOX2+ nonradial cells,
we could not detect any increase in the number of cleaved Cas-
pase 3+ nuclei in the SGZ. Thus, the cellular loss among the
SOX2+ nonradial pool was probably due to a decreased produc-
tion of SOX2+ nonradial cells but not to enhanced cell death.
Cell Stem Cell
BMPs Regulate Adult Neural Stem CellsBMPR-IA and Smad4 Are Required for Maintaining
AH-NSC Activity and Neurogenesis In Vivo
We next designed a cell type- and time-specific strategy to accu-
rately examine the role of canonical BMP signaling downstream
of BMPR-IA in the regulation of AH-NSCs. We developed a lenti-
virus (LV)-mediated knockout technique to selectively delete
Bmpr1a in Sox2-expressing cells (Figure 7A). Bmpr1aflox/null
mice were stereotactically injected into the dentate gyrus with
a LV expressing Cre recombinase fused to GFP under the
regulation of the Sox2 promoter (LV-Sox2-CreGFP). As a control,
Bmpr1aflox/wt and Bmpr1aflox/null mice were injected with LV-
Sox2-CreGFP or LV-Sox2-GFP, respectively. Animals received
BrdU either 10 days or 4 weeks after LV injection. Among the
LV-infected cells (GFP+), the percentage of P-SMAD1+ cells
declined from 74.6% ± 5.7% (average ± SEM) in control mice
to 38.5% ± 7.7% inBmpr1aflox/null mice, indicating that canonical
signaling was impaired. Ten days after Bmpr1a deletion, prolifer-
ation was increased in the SGZ, although high experimental
variability and a local inflammatory response were observed.
To analyze long-term effects of conditional Bmpr1a deletion in
NSCs, we examined animals 28 days after LV injection. At this
late time point, proliferation was markedly decreased (57%
reduction, p < 0.05, Figures 7C and 7D), which is in accordance
to our previous observations. Consistent with this finding, the
total number of SGZ SOX2+ cells was 51% lower (p < 0.05,
Figures 7D and 7E), and the number of DCX+ immature neurons
was strongly reduced (p < 0.05, Figures 7D and 7F), indicating
that neurogenesis was severely impaired upon deletion of
Bmpr1a.
We next used a genetic approach to conditionally delete
Smad4, a central player of the canonical BMP pathway, in the
radial NSC population. We took advantage of the GLAST:
CreERT2 mouse line that expresses the tamoxifen-inducible
form of Cre in adult NSCs (Ninkovic et al., 2007). GLAST:
CreERT2 animals were crossed with the Smad4flox/flox mouse
line, and after tamoxifen-induced deletion of Smad4, dividing
cells were labeled by means of BrdU. Animals were examined
either immediately after or 3 weeks later (Figure 7G). We
observed an increase in BrdU incorporation in the SGZ of condi-
tionally deleted Smad4 mice that were analyzed at short time
points (BrdU+ cells per mm3: 751 ± 213 in Smad4wt/wt versus
1733 ± 47 in Smad4flox/flox, p < 0.05, Figure 7H), yet when mice
were examined 3 weeks later, we observed a reduction in
SOX2+ cell numbers, which was attributed to a decrease in non-
radial cells (Figures 7I and 7J). This finding is in accordance with
our previous data and clearly indicates that Bmpr1a and Smad4
are involved in regulating the activity and the number of stem/
precursor cells in the adult SGZ.
Our results demonstrate that canonical BMP signaling down-
stream of the BMP type IA receptor plays a key role in vivo in
regulating quiescence of radial NSCs, which is required to main-
tain the proliferative capacity of the hippocampal stem cell pool
and thus to support continuous neurogenesis throughout the
adult life.
DISCUSSION
Interactions between neurogenic niches and NSCs play a critical
role in the homeostatic regulation of adult neurogenesis.Signaling from the niche is proposed to control many aspects
of NSC behavior, such as balancing the quiescent and prolifera-
tive status of NSCs (in order to regulate the rate of neurogenesis),
determining the cell division mode (symmetric versus asym-
metric, to preserve the NSC pool), and preventing premature
depletion of stem cells, or the loss of their properties, to maintain
neurogenesis throughout life (Morrison and Spradling, 2008;
Miller and Gauthier-Fisher, 2009). Disrupted homeostatic influ-
ence of neurogenic niches onto NSCs can promote pathological
conditions such as cellular aging and tumorigenesis (Voog
and Jones, 2010). Thus, identifying and understanding niche
signals can shed light on how adult neurogenesis is regulated
and can provide a key to successful NSC-mediated regenerative
medicine.
Here, we have addressed the function of BMP signaling in the
hippocampal stem cell niche from fully mature mice by combining
in vitro experiments, brain infusion of the antagonist Noggin,
label-retaining assays, and conditional inactivation of Bmpr1a
or Smad4 in stem cells. On the basis of our findings, we propose
that BMPs participate as dominant niche signals in the adult
hippocampus to restrict proliferation of the stem cell pool. All
our studies supported this notion, demonstrating that (1) BMP
canonical signaling is active in the majority of the SOX2+ cell pop-
ulation in the hippocampus, which is predominantly out of the cell
cycle (Suh et al., 2007), including the BMPRI-A+ radial stem cell
pool; (2) BMP canonical signaling is blocked in SOX2+ cells that
actively proliferate and incorporate BrdU; (3) BMPs reversibly
counteract the mitogenic stimulation of cultured SOX2+ AH-
NSCs, driving the cells into quiescence; and (4) downregulation
of endogenous BMP signaling increases proliferation of SOX2+
cells in the hippocampus by recruiting quiescent (G0) radial cells
into the cycle and consequently leads to enhanced neurogene-
sis. Thus, the ultimate role of BMPs in the adult hippocampal
niche is to govern the balance between the quiescent and prolif-
erative state of NSCs, thereby modulating stem cell activity and
neurogenesis in the SGZ. These results consolidate BMP ligands
and BMPR-IA signaling as widespread regulators of stem cell
division in a variety of adult somatic niches (Varga and Wrana,
2005; Morrison and Spradling, 2008). In addition, we have also
found that canonical signaling becomes reactivated in the
hippocampus shortly after neuronal fate commitment, possibly
implicating the BMPR-IB receptor in the maturation and/or cell
cycle exit of newly born neurons (Figure S7).
Our studies also provided a mechanistic understanding of how
BMPs transduce signals into NSCs. BMPR-IA is responsible for
triggering the canonical BMP pathway by phosphorylating the
SMAD1 protein. Using both adherent and neurosphere stem
cell cultures, we have found that the canonical BMP pathway
primarily acts to restrict AH-NSC division in the presence of
a mitogenic stimulus without affecting stem cell identity. The
decrease in proliferation is due, at least in part, to an increase
in the proportion of cells that enters quiescence. The effect is
reversible and proliferation is resumed once the culture is
depleted of BMP. Moreover, translocation of P-SMAD1 is asso-
ciated with the upregulation of target genes, such as Id1-4 and
Hes1. All the aforementioned genes are known to block the
action of prodifferentiation bHLH factors in the developing
ventricular zone of the central nervous system (Ishibashi et al.,
1994; Nakashima et al., 2001; Ohtsuka et al., 2001; HatakeyamaCell Stem Cell 7, 78–89, July 2, 2010 ª2010 Elsevier Inc. 85
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Figure 7. Conditional Ablation of Bmpr1a or Smad4 Compromises Stem Cell Maintenance and Neurogenesis
(A) Scheme illustrating the LV-based strategy for selective deletion of the Bmpr1a allele in Sox2-expressing cells. BrdU was administered prior to sacrifice, either
10 days or 4 weeks after LV injection.
(B) Box and whiskers plot showing that median proliferation is increased inBmpr1aflox/null mice injected with the LV expressing GFP/Cre fusion in SOX2+ cells after
10 days. Note the dispersion of the data at this early time point (Mann-Whitney U-test, p < 0.05).
(C) Proliferation is significantly decreased in Bmpr1aflox/null mice injected with the LV expressing GFP/Cre after 4 weeks. No change was observed in noninjected
contralateral hemispheres (control) or in Bmpr1aflox/null mice injected with the LV expressing GFP.
(D) Immunohistochemical analysis of Bmpr1aflox/null and Bmpr1aflox/wt mice injected with the LV expressing GFP/Cre after 4 weeks. The number of proliferating
cells (bottom, BrdU+, red), the number of stem/precursor cells (middle, SOX2+, blue), and the number of new neurons (top, DCX+, gray) were reduced. SGZ
LV-infected cells expressing GFP (green) are shown in the bottom panel.
(E) Quantitative analysis of Bmpr1aflox/null and Bmpr1aflox/wt mice injected with the LV expressing GFP/Cre demonstrates the depletion in SOX2+ cells.
(F) The reduction in the number of DCX+ neurons observed in (D).
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BMPs Regulate Adult Neural Stem Cellset al., 2004). Induction of the Hes1 gene is particularly interesting
because HES1 can act as a safeguard against irreversible
cell cycle exit during quiescence, thereby possibly preventing
premature senescence and inappropriate differentiation of AH-
NSCs (Sang et al., 2008). As opposed to the BMP treatment,
the addition of the antagonist Noggin to neurosphere cultures
increased the number of spheres, their diameter, and the per-
centage of cells per sphere that were in the cell cycle, indicating
that AH-NSCs secrete BMPs, which may act to regulate prolifer-
ation in an autocrine manner.
A relevant aspect of our in vivo results is that although
blockade of BMP signaling in the hippocampus first stimulates
proliferation, it leads subsequently to the loss of the regenerative
capacity of the radial stem cell population. The early impact of
Noggin infusion is an increase in proliferation, but the conse-
quence after 3 weeks is a reduction in proliferation and a
depletion of newborn neurons (which were also detected in
Smad4- and Bmpr1a-deleted animals). Importantly, by consec-
utively labeling cells with CldU and IdU, we observed that
CldU+IdU+ double-positive cells in the SGZ were diminished
4 weeks after the onset of Noggin infusion, pointing to a restric-
tion in the proliferative activity of the LRCs that were challenged
to divide earlier. This finding differs from a recent report showing
that continuous Noggin release from neuronal cells increases
the number of slowly dividing LRCs (Bonaguidi et al., 2008).
However, in that study, the interval between the administration
of the two thymidine analogs was shorter, perhaps explaining
their different results. Alternatively, it is possible that acute
delivery of Noggin by pump infusion may have caused a
response that differs from the effect triggered by a continuous
Noggin release. Interestingly, we also observed that 4 weeks
after blocking the BMP pathway, the number of nonradial SOX2+
cells was reduced, whereas the number of SOX2+ GFAP+ radial
cells remained constant. This observation is compatible with
a model in which the production of nonradial cells by adult
hippocampal radial NSCs in vivo becomes compromised after
a certain number of mitotic rounds, resembling the behavior of
NSCs in the aged hippocampus (Hattiangady and Shetty,
2008; Aizawa et al., 2009). In conclusion, our interpretation of
the data presented herein is that a prolonged blockade of the
BMP pathway can lead to a premature loss in the ability of
activated hippocampal stem cells to proliferate and generate
progeny in vivo. However, at later time points, feedback mecha-
nisms elicited by the decline in stem cell activity could recruit
a backup of dormant NSCs to replenish the niche.
Together, our findings reveal an aspect of BMP signaling in
adult NSC niches, as a master regulator of quiescence, and
may provide a key to understanding the maintenance of neuro-
genesis in the adult hippocampus. At the same time, our studies
raise several questions regarding BMP function. First, it is
tempting to speculate that the effects of diverse neurogenic
external stimuli, such as learning, voluntary exercise, enriched(G) Diagram illustrating the experimental design employed for the selective delet
10 days after the administration of tamoxifen. Animals were either sacrificed imm
(H) Soon after tamoxifen treatment, proliferation in the SGZ of Smad4 conditiona
(I and J) Three weeks later, the number of nonradial precursors diminished but th
maximal projection of a 17-micron stack. GFAP staining is shown in red, SOX2 is s
The scale bar represents 40 mm.environment, or treatment with antidepressant drugs (reviewed
by Ming and Song, 2005; Zhao et al., 2008), may converge
mechanistically on an increase in inhibitory factors that block
BMP signaling. In support of this view, it has been reported
that running increases Noggin expression and decreases
Bmp4 expression in hippocampal tissue, and the resulting
blockade of BMP signaling is crucial for the effects of exercise
on neurogenesis and cognition in mice (Gobeske et al., 2009).
In contrast, it has been shown that decreased neurogenesis in
a transgenic mouse model of Alzheimer’s disease is accompa-
nied by increased expression of Bmp4 and decreased expres-
sion of Noggin (Tang et al., 2009), pointing to a broad role for
the niche’s balance of BMP antagonists/ligands in controlling
adult NSCs. However, the identification of the cellular source
of BMP ligands and antagonists in vivo needs to be investigated
further. Second, as shown in our in vitro studies, BMPs coun-
teract mitogenic signals such as FGF2; thus, understanding
the interplay between the BMP pathway and other signaling
pathways may be crucial to unraveling how adult NSC division
is balanced. Among the endogenous molecules that are
expressed in the dentate gyrus of rodents and that have been
shown to regulate hippocampal NSCs, Shh (Favaro et al.,
2009) and Wnt3 (Lie et al., 2005) may be relevant (Figure S7).
Given the antagonistic function of BMP and Shh in mediating
the development of some central nervous system structures,
and given the role of the fine-tuned activity of the BMP and
Wnt pathways in the switch from stem cell quiescence to active
proliferation in several adult organs (reviewed by Li and Clevers,
2010), future attempts should be made to understand the
function of BMP signaling in a context-dependent manner.EXPERIMENTAL PROCEDURES
Cell Culture
For proliferation and electroporation assays, AH-NSCs were grown as
described in Supplemental Experimental Procedures. Recombinant BMP2/
BMP4 (R&D Systems) and Noggin (Sigma) were added at the indicated
concentrations.
Immunostaining
Tissue and cultured cells were fixed with 4% paraformaldehyde and pro-
cessed for immunostaining. Primary and secondary antibodies employed
are listed in Supplemental Experimental Procedures. Stained specimens
were analyzed with either a Bio-Rad Radiance confocal imaging system
(Hercules, CA), a Leica TCS-SL spectral confocal (Heidelberg, Germany), or
a Nikon Eclipse 800 microscope (Nikon, Melville, NY).
Flow Cytometry
Analysis was performed on Hoechst 33342 (Sigma) and Pyronin Y (Sigma)
stained cells with a FACSVantage cytometer (Becton Dickinson), as described
in Supplemental Experimental Procedures. Oregon Green 488 carboxylic acid
diacetate succimidyl ester (DFFDA, Molecular Probes) was used for staining
neurospheres. DFFDAhigh cells were sorted in FACSAria (Becton Dickinson)
equipment.ion of Smad4 in GLAST-expressing adult radial stem cells. BrdU was injected
ediately after or 3 weeks later.
l knockouts was increased.
e number of radial NSCs remained unchanged. The confocal image shows the
hown in green, and DAPI is shown in blue. Unpaired Student’s t test: *p < 0.05.
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Infusion was performed using Alzet osmotic mini-pumps (see Supplemental
Experimental Procedures for additional details). In one experimental para-
digm, animals were injected intraperitoneally with 50 mg BrdU/kg of body
weight (seven times, once every 2 hours) on the last day of infusion and
were sacrificed 1 hr after the last injection. In a second experimental paradigm,
CldU (42.5 mg/kg) was injected on the last day of infusion (three times every
2 hr). Next, the catheter connecting the pump to the cannula was sealed. After
3 additional weeks, animals received IdU (57.5 mg/kg) over 3 days (six times
every 12 hr) and were sacrificed 12 hr after the last injection. Handling of
mice was carried out in accordance with 86/609/EEC guidelines. The animal
procedures were performed in accordance with protocols approved by the
Instituto de Salud Carlos III animal care and use committee.
Lentiviral Vectors and In Vivo Injections
Lentiviral vectors expressed either GFP or GFP/Cre fusion protein under the
control of Sox2 promoter. A total of 1.5 ml of the viral concentrate was stereo-
tactically injected into the right hippocampal dentate gyrus (see Supplemental
Experimental Procedures for additional details). Ten days post-surgery, ani-
mals were injected intraperitoneally with BrdU four times at 2 hr intervals
and were sacrificed two hours after the last injection. A separate group of
animals was injected with BrdU four weeks post-surgery, once daily for three
consecutive days, at a dose of 100 mg/kg body weight. Animals were perfused
24 hr after the final BrdU injection. All animal procedures were performed
according to protocols approved by The Salk Institute for Biological Studies
animal care and use committee.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and seven figures and can be found with this article online at doi:10.1016/j.
stem.2010.04.016.
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